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ABSTRACT
In most patients with acute leukemia, the generation time of leukemic cells is about
(10 hours, longer than for normal cells. Approximate times for the phases of the cell cycle
are: DNA synthesis (S), 20 hours; mitosis (M), 2 hours; and the post-synthesis and post-
mitosis rest phases (G2 and Gi), 2 and 36 hours, respectively. A most important finding
has been that a variable proportion of leukemic cells are out of cycle, that is, are in a
resting or Go state. These resting cells are in equilibrium with the dividing cells, and
some, as yet unknown, control mechanism for leukemic-cell growth controls the flow of
cells from one compartment to the other. A critical feature of the resting cells is that
they are relatively resistant to cycle-dependent chemotherapeutic agents.
Much information has been obtained concerning the effects of drugs on the pro-
liferative characteristics of leukemic cells. This information provides the basis for
designing regimens with better timing of drug administration and advantageous use of
combined chemotherapy.
INTRODUCTION
A favorite ploy of history teachers is to reveal to their students that the Holy
Roman Empire was badly misnamed because it was not holy, Roman, nor an
empire. In a similar vein, for generations, physicians have conceived of the
leukemic process as one of rapid, uncontrolled proliferation of abnormal cells.
During the past few years, however, it has become apparent that this concept of
malignant cell growth was likewise erroneous. From the kinetic studies of leukemic
cells to be discussed in this paper, the proliferative rate is slower than that of
normal cells, and there is evidence for a rather sophisticated system of growth-
regulatory mechanisms.
Early indication that leukemic-cell growth rates are less than for normal
blood-cell precursors was presented by Astaldi and Mauri (1953). With the
advent of radioisotopically labeled DNA and RNA precursors shortly thereafter,
methods became available for specific studies of leukemic-cell proliferative char-
acteristics. As knowledge of these characteristics has accumulated, attempts to
correlate chemotherapy and cell kinetics have been possible. Information con-
cerning the pathophysiology of the leukemic process has become available. Of
particular value have been the concepts derived from kinetic studies which have
application for design of chemotherapeutic regimens. Therefore kinetic studies of
acute leukemia have been of value as one of the several possible approaches to an
understanding of the disease process.
METHODS OF STUDY
The earliest possible method of study was the measure of the number of mitotic
figures present in the leukemic-cell population in comparison to that of normal
dividing cells (Astaldi and Mauri, 1953). The measure of mitotic indices (Japa,
1942) continues to be of value in judging overall proliferative activity and re-
sponse of the leukemic cells to chemotherapy.
The advent of labeled DNA and RNA precursors added a new dimension to
the study of cell proliferation. Most commonly used is 3H-thymidine (3HT)
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which specifically is incorporated into DNA only during the DNA synthetic phase
of the cell cycle and remains with the cell in the nuclear DNA (Hughes, 1970).
A labeling index with 3HT obtained by autoradiography therefore gives an indi-
cation of the percent of cells in DNA synthesis within the cell population, another
measure of overall proliferative activity. Another assessment of DNA synthetic
activity within a cell population can be obtained by measuring the incorporation of3H- or 14C-labeled thymidine into the DNA by means of liquid scintillation count-
ing techniques (Lampkin, et al., 1971).
An important consideration is the time required for the various phases of the
cell cycle: mitosis (M); the interphase between mitosis and DNA synthesis (Gi);
DNA synthesis (S); and the period between S and M (G2). The total time re-
quired from one mitosis to a subsequent mitosis is the generation time. Another
measure which is sometimes used is the time required for a dividing population to
double in number. If all cells divide in a similar fashion within the population
and no loss of cells occurs, the doubling time and generation time are the same.
In most cell populations, however, not all cells are engaged in proliferative activity
and some loss of cells does occur. Therefore in most situations the population-
doubling time is slower than the cell-generation time.
Recently it has been possible to determine the content of cellular DNA by
microspectrophotometry, a technique that has been used in some studies of
leukemic-cell kinetics (Ernst and Killman, 1970). Coupled with 3HT labeling
and autoradiography, the technique can give information about the distribution
of cells within the DNA synthesis phase for cells just beginning the phase, with
nearly normal DNA content, to cells almost finished the phase, with twice normal
DNA content. Cells in G2 are found to have twice normal DNA content, but
are unlabeled because DNA synthesis has been completed. This time-consuming
type of study is useful for some special situations.
Several methods have been used to assess the timing of the generation cycle.
The most difficult has been the observation of labeling in mitotic figures after a
single in vivo injection of 3HT. The label is incorporated rapidly into nuclei of
cells in DNA synthesis and is available for only about 20 to 30 minutes (Rubini,
et al., 1960). Thus, "flash" labeling is obtained. The labeled cells, representing
the cohort in DNA synthesis at the time of injection, subsequently complete DNA
synthesis and proceed to the following phases of the generation cycle. This
progress can be followed by serial samples of the cell population, by means of
bone-marrow aspiration in the case of acute leukemia. A clear marker for ob-
serving the progress is the appearance and disappearance of the labeled cells in
the mitotic phase, where the labeled cells can be distinguished by their altered ap-
pearance. The time for appearance of labeled mitotic figures represents the time
needed to go through G2. The time from mid-point of appearance to mid-point
of disappearance of the labeled mitotic figures represents the time required for
DNA synthesis. When the next wave of labeled mitotic figures appears, the
generation time for these cells is indicated.
Another method of measuiring generation time that has been used has been
the serial determination of grain counts in labeled cells. The label, once incor-
porated, becomes diluted in daughter cells by one-half during each mitotic division
(Cronkite, et al., 1961). Therefore, by determining the half-time for descreasing
mean grain counts, the generation time should be possible to measure. Un-
fortunately, in practice, this method is not suitable. There is some label reutiliza-
tion and furthermore some entry of cells into a prolonged rest phase (Go), which
affects the rate of label concentration decrease in the cell population.
A more rapid measure of DNA synthesis time can be obtained with a double-
labeling technique. By this method, 3HT is injected in vivo and at some time
thereafter marrow is aspirated and incubated with 14CT in vitro. Cells labeled
with 3HT and 14CT can be distinguished by special autoradiographic techniques.
No. 1 SYMPOSIUM ON LEUKEMIA 13
From the ratio of 3HT-labeled cells to doubly labeled cells and the elapsed time
between labeling procedures, the DNA synthesis time can be determined.
Effects of chemotherapeutic agents on proliferative activity can be measured
by obtaining serial determinations of labeling indices and mitotic indices follow-
ing administration of the agent. In some special situations, such as the study of
methotrexate effect, two labels can be used. In this case, 3HT will be incorporated
by affected cells because this compound is beyond the metabolic block imposed
by the drug. Thus cells capable of DNA synthesis but blocked by methotrexate
will be demonstrated. On the other hand, 3H-deoxyuridine (3H-dU) will not be
incorporated by affected cells, because the block prevents production of the thy-
midine needed for DNA synthesis from this precursor substance. Thus the de-
gree and duration of the methotrexate effect will be determined with the label.
GENERAL FEATURES OF LEUKEMIOCELL KINETICS
Several recent review articles giving details about cell kinetics in acute leukemia
are available (Cronkite, 1967; Killman, 1968). From studies of the generation
cycle with the labeled mitotic-index technique, the times for cell division are
determined to be longer than for normal hematopoietic cells (Saunders, et al.,
1967; Wagner, et al., 1972). The generation time is in the range of 50 to 70 hours,
with S about 20 hours, G2 about 2 hours, M about 2 hours, and Gi about 30 to
35 hours. Some variation from patient to patient has been observed in these
times.
From the earliest studies of the patterns of cell proliferation in acute leukemia,
there has been indication that the cell population is not uniform with respect to
prliferative activity. Labeling indices with 3HT indicated that leukemic cells in
blood had a lesser degree of proliferative activity than did the bone-marrow-cell
population (Mauer and Fisher, 1962). Even in the bone marrow, there are two
functionally different cell populations discernible (Gavosto, et al., 1967; Mauer
and Fisher, 1966; Killman, 1965). One population of larger cells with fine nuclear
chromatin is the proliferative compartment. The other, comprised of smaller
cells with dense nuclear chromatin, is a compartment of cells exhibiting no pro-
liferative activity. The smaller cells arise from the larger cells, as some of these
cells drop out of the proliferative cycle to become resting cells.
It was observed by Gavosto and co-workers (1967) that the larger cell com-
partment was non-self-maintaining, in that the loss of cells to the resting com-
partment was greater than the birth rate of larger cells. Therefore a source of
cells coming into proliferative activity had to be found. Subsequently, it was
demonstrated that small, resting leukemic cells were capable of reentering the
proliferative phase and thus could serve as a stem-cell compartment for the larger
cells (Saunders and Mauer, 1969). The cell population was in a dynamic equi-
librium between resting and proliferative phases. The resting cells would then
be only temporarily out of phase (in Go). This population of resting cells, less
sensitive to phase-dependent chemotherapeutic agents but capable of return to
proliferative activity, has obvious importance for design of treatment regimens.
Furthermore, in considering the pathogenesis of acute leukemia, these findings are
compatible with a single cell mutation forming a self-maintaining clone of malignant
cells.
EVIDENCES OF CONTROL MECHANISMS FOR LEUKEMIC-CELL GROWTH
One of the earliest indications that some control over leukemic-cell prolifera-
tion exists was the observation that proliferative activity was similar in various
marrow sites sampled either simultaneously (Mauer and Fisher, 1966) or during
different times of the day (Saunders, et al., 1967). This finding would suggest
that systemic humoral substances, not local environmental conditions, were
probably responsible for proliferation control (Mauer, et al., 1972).
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It was also observed that considerable variation in proliferative activity occurs
from patient to patient, and even in the same patient during different phases of
his disease (Foadi, et al., 1967; Pileri, et al., 1967; Saunders, et al., 1967). In
general, the least degree of proliferative activity occurs at the time of diagnosis,
when, from duration of symptoms, one would expect the longest growth period
for the cell population to have been possible. On the other hand, when the popu-
lation is studied in a subsequent relapse, proliferative activity of the cells is greater.
At this time, the duration of symptoms, if any, is short, and it would be expected
that the duration of population growth is also short. The proliferative activity
varies inversely with the number of resting leukemic cells.
The most probable explanation for these findings is that, with progressive
duration of growth, there is an increasing number of cells entering into the resting
phase. The nature of the mechanisms controlling the change in proliferative
activity is not known, but again, because of the similarity of samples obtained
from various marrow sites, the agent would most likely be systemic and humoral,
rather than local environmental determinants. In many respects this system
resembles the changes in growth rates observed in broth-grown bacteria or in cells
grown in tissue culture with increasing population density.
Another indication of control mechanisms is the equilibrium achieved between
resting and proliferating compartments. Some method of maintaining this rather
sophisticated interchange of cells must exist, because, for periods as long as 9
days, the balance can be maintained (Saunders and Mauer, 1969). Leukemic
cells have even been found to respond to some normal control mechanism because
in some patients a normal circadian pattern of mitotic activity is found (Saunders,
et al., 1967).
The mechanisms for control of leukemic cell growth are of obvious importance.
From studies of a computer-simulated model of leukemic-cell kinetics, an important
possible site of action is the time right after mitotic division, when the cell either
returns promptly to the mitotic cycle for another division or goes into a resting
phase (Mayer, et al., In press). The metabolic events at that time in the cell are
not well understood in relationship to the important decision in the cell's life.
Another factor determining overall population-growth rates is cell death, a factor
well appreciated in solid tumors but on which no information is available for
leukemica.
An exciting and useful tool for treatment of acute leukemia has come from the
observation that leukemic-cell proliferative activity can be perturbed by chemo-
therapeutic manipulation (Lampkin, et al., 1971). With the drug effects of some
agents are associated secondary effects on the population-control mechanics such
that resting cells can be recruited into proliferative activity. Similar recruitment
has been reported with extra-corporeal irradiation of blood leukemic cells (Chan
and Hayhoe, 1971), but has not been possible by reducing the blood-leukemic-cell
concentration with exchange transfusion (Lampkin, et al., 1971) or leukapheresis
(Reich, et al., 1971). Because of the relative resistance of resting cells to cycle-
dependent chemotherapeutic agents, the possibility of goading these cells into a
drug-senstitive state presents a tantalizing opportunity. There is much of po-
tential value to be learned from further studies of those control mechanisms
regulating leukemic-cell growth.
Recently a new tool for study for growth regulation of cells in acute myeloblastic
leukemia has become available. By means of in vitro culture methods, the in-
fluence of normal growth factors for myeloid cells can be assessed in malignant
cell populations. These studies are already making evident that some leukemic
cells respond to these normal factors by altering their growth and maturation pat-
terns. Further definition of the relationship of normal myeloid growth factors
to the leukemic cell in acute myeloblastic leukemia is awaited with obvious interest.
Similar techniques applied to acute lymphoblastic leukemia would be an important
advance in our study of that disease.
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This textbook was first published in 1963 for use in university-level ecology courses in Russia.
As such it provides an introduction to the flora, fauna, and ecology of the Soviet Union, a biota
that is unfamiliar to most ecologists. Much of this information is contained in the nearly 350
tables and figures that illustrate the text. Nearly all of the analyses are graphic in nature and
much of the quantitative detail of the studies is lost.
More importantly, this book is an historical document reflecting the philosophical basis
for the study of ecology within the Soviet Union in the early 1960's. In an attempt to rectify
ecology with Marxist doctrines, it embodies the then-accepted views of Lysenko, which denied
any relationship between genetics and evolution, and which emphasized the inheritance of ac-
quired characters. It is also concerned with practical aspects of ecology, particularly in regard
to agriculture and game management. Its discussions of the ecology of individuals, populations,
and communities are often narrow, and have a curiously 19th-centurish air about them.
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